Nektar Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2024
Amgen 2.78 0.17 Mar/2026
Baxter International 2.14 0.58 Mar/2026
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 4.12 3.9 Mar/2026
Cara Therapeutics 0 0 Mar/2025
Cipla 1.06 0.2 Mar/2026
Dr.Reddys Laboratories 0.64 0.01 Mar/2026
Eisai 3.28 0.07 Mar/2026
Eli Lilly 0.58 0.16 Dec/2025
Esperion Therapeutics 0 0 Mar/2025
Gilead Sciences 2.29 0.29 Mar/2026
GlaxoSmithKline 0.82 3.75 Mar/2026
Grifols EUR 1.88 0.68 Dec/2025
Karyopharm Therapeutics 0 0 Mar/2025
Merck 2.76 0.36 Mar/2026
Nektar Therapeutics 0 0 Mar/2025
Novartis USD 3.33 0.29 Mar/2026
Pfizer 6.36 0.55 Mar/2026
Roche Holding 2.96 0.8 Dec/2025
Takeda 1.65 2.43 Mar/2026